The multiple condition (MC)-retention model is an uncertainty-aware graph-based neural network that predicts liquid chromatography (LC) retention times across multiple column chem ...

Artificial intelligence is fundamentally changing how software is built. It is moving beyond just speeding up tasks. AI is ...

Machine learning has moved past its initial experimental phase. In earlier years, development often focused on creating the ...

By Lorna Patrick, Chief Operating Officer, Upperton In the world of outsourced drug development and manufacturing, risk ...

The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...

Meta's Muse Spark brings multimodal reasoning, health AI, and multi-agent orchestration to users via meta.ai and a private ...

The old measurements of leverage, utilization, margin, billing rate, and realization fall short of the new reality.

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

Celonis' Christoph Schettler declares that the era of reactive supply chains is over. As geopolitical disruptions in critical ...

Muse Spark is Meta’s new multimodal reasoning model built for Meta AI. Here is a clear analysis of its capabilities, ...

Meta has introduced Muse Spark, a new AI model developed by Meta Superintelligence Labs. The model is part of a broader Muse ...

Curious how 6G will power unmanned operations in remote spots like mining sites or disaster zones? A new Engineering study ...